| Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a … RK Kelley, M Ueno, C Yoo, RS Finn, J Furuse, Z Ren, T Yau, HJ Klümpen, ... The Lancet 401 (10391), 1853-1865, 2023 | 522 | 2023 |
| Proton-pump inhibitors: understanding the complications and risks P Malfertheiner, A Kandulski, M Venerito Nature Reviews Gastroenterology & Hepatology 14 (12), 697-710, 2017 | 299 | 2017 |
| European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients OP Nyssen, D Bordin, B Tepes, Á Pérez-Aisa, D Vaira, M Caldas, ... Gut 70 (1), 40-54, 2021 | 257 | 2021 |
| Meta-Analysis of Bismuth Quadruple Therapy versus Clarithromycin Triple Therapy for Empiric Primary Treatment of Helicobacter pylori Infection M Venerito, T Krieger, T Ecker, G Leandro, P Malfertheiner Digestion 88 (1), 33-45, 2013 | 224 | 2013 |
| Gastric cancer: epidemiology, prevention, and therapy M Venerito, R Vasapolli, T Rokkas, P Malfertheiner Helicobacter 23, e12518, 2018 | 209 | 2018 |
| Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial JM Llovet, M Kudo, P Merle, T Meyer, S Qin, M Ikeda, R Xu, J Edeline, ... The lancet oncology 24 (12), 1399-1410, 2023 | 204 | 2023 |
| S2k-leitlinie helicobacter pylori und gastroduodenale Ulkuskrankheit W Fischbach, P Malfertheiner, PL Jansen, W Bolten, J Bornschein, ... Zeitschrift für Gastroenterologie 54 (04), 327-363, 2016 | 200* | 2016 |
| Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis P Gharahkhani, RC Fitzgerald, TL Vaughan, C Palles, I Gockel, ... The lancet oncology 17 (10), 1363-1373, 2016 | 191 | 2016 |
| Nutrition in patients with gastric cancer: an update R Rosania, C Chiapponi, P Malfertheiner, M Venerito Gastrointestinal tumors 2 (4), 178-187, 2016 | 190 | 2016 |
| PET/MRI in head and neck cancer: initial experience I Platzek, B Beuthien-Baumann, M Schneider, V Gudziol, J Langner, ... European journal of nuclear medicine and molecular imaging 40, 6-11, 2013 | 166* | 2013 |
| Gastric cancer–clinical and epidemiological aspects M Venerito, A Link, T Rokkas, P Malfertheiner Helicobacter 21, 39-44, 2016 | 154 | 2016 |
| Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial MA Tempero, U Pelzer, EM O'Reilly, J Winter, DY Oh, CP Li, G Tortora, ... Journal of Clinical Oncology 41 (11), 2007-2019, 2023 | 113 | 2023 |
| Feasibility of double-balloon enteroscopy-assisted chromoendoscopy of the small bowel in patients with familial adenomatous polyposis K Mönkemüller, LC Fry, M Ebert, M Bellutti, M Venerito, C Knippig, ... Endoscopy 39 (01), 52-57, 2007 | 92 | 2007 |
| Helicobacter pylori infection is associated with a reduced risk of developing eosinophilic oesophagitis U Von Arnim, T Wex, A Link, M Messerschmidt, M Venerito, S Miehlke, ... Alimentary pharmacology & therapeutics 43 (7), 825-830, 2016 | 90 | 2016 |
| Helicobacter pylori, gastric cancer and other gastrointestinal malignancies M Venerito, R Vasapolli, T Rokkas, JC Delchier, P Malfertheiner Helicobacter 22, e12413, 2017 | 83 | 2017 |
| Adverse event profile during the treatment of Helicobacter pylori: a real-world experience of 22,000 patients from the European registry on H. pylori management (Hp-EuReg) OP Nyssen, A Perez-Aisa, B Tepes, M Castro-Fernandez, J Kupcinskas, ... Official journal of the American College of Gastroenterology| ACG 116 (6 …, 2021 | 74 | 2021 |
| Serological prevalence of Helicobacter pylori infection in Saxony-Anhalt, Germany, in 2010 T Wex, M Venerito, J Kreutzer, T Götze, A Kandulski, P Malfertheiner Clinical and vaccine immunology 18 (12), 2109-2112, 2011 | 74 | 2011 |
| Helicobacter pylori Infection: New Facts in Clinical Management P Malfertheiner, M Venerito, C Schulz Current treatment options in gastroenterology 16, 605-615, 2018 | 71 | 2018 |
| Gastric cancer—clinical aspects M Venerito, A Link, T Rokkas, P Malfertheiner Helicobacter 24, e12643, 2019 | 69 | 2019 |
| Autoimmune gastritis in autoimmune thyroid disease M Venerito, M Radünz, K Reschke, D Reinhold, K Frauenschläger, ... Alimentary Pharmacology & Therapeutics 41 (7), 686-693, 2015 | 69 | 2015 |
